- Title
- The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland : results from the LIPIDOGRAM2015 study
- Creator
- Jóźwiak, Jacek; Studziński, Krzysztof; Tomasik, Tomasz; Windak, Adam; Charchar, Fadi
- Date
- 2020
- Type
- Text; Journal article
- Identifier
- http://researchonline.federation.edu.au/vital/access/HandleResolver/1959.17/180062
- Identifier
- vital:15692
- Identifier
-
https://doi.org/10.1016/j.atherosclerosissup.2021.01.004
- Identifier
- ISBN:1567-5688 (ISSN)
- Abstract
- Background and aim: To estimate the prevalence of cardiovascular (CV) disease and CV risk factors among Polish patients. Methods: A nationwide cross-sectional study, LIPIDOGRAM2015, was carried out in Poland in the 4th quarter of 2015 and 1st and 2nd quarters of 2016; 438 primary care physicians enrolled 13,724 adult patients that sought medical care in primary health care practices. Results: Nearly 19% of men and approximately 12% of women had cardiovascular disease (CVD). Over 60% of the recruited patients had hypertension (HTN), >80% had dyslipidaemia and <15% of patients were diagnosed with diabetes (DM). All of these disorders were more frequent in men. In 80% of patients the waist circumference exceed norm for the European population. Less than half of the patients were current smokers or had smoked in the past. Patients with CVD had significantly higher blood pressure and glucose levels but lower low density lipoprotein-cholesterol level. Conclusions: The prevalence of CVD and CV risk factors among patients in Poland is high. CVD is more common in men than in women. The most common CV risk factors are excess waist circumference, dyslipidaemia and HTN. Family physicians should conduct activities to prevent, diagnose early and treat CVD in the primary health care population. © 2021 Elsevier B.V. **Please note that there are multiple authors for this article therefore only the name of the first 5 including Federation University Australia affiliate “Fadi Charchar” is provided in this record**
- Publisher
- Elsevier Ireland Ltd
- Relation
- Atherosclerosis Supplements Vol. 42, no. (2020), p. e15-e24
- Rights
- All metadata describing materials held in, or linked to, the repository is freely available under a CC0 licence
- Rights
- http://creativecommons.org/licenses/by-nc-nd/4.0/
- Rights
- Copyright © 2021 Elsevier B.V.
- Rights
- Open Access
- Subject
- 1102 Cardiorespiratory Medicine and Haematology; 1103 Clinical Sciences; Cardiovascular disease; Cardiovascular risk factors; Diabetes mellitus; Hypercholesterolaemia; Hypertension; Obesity; Poland; Primary health care
- Full Text
- Reviewed
- Funder
- The present study was an initiative of the Polish Lipid Association (PoLA) and the College of Family Physician in Poland (CFPiP). The present study was funded by an unrestricted educational grant from Valeant. As a supporter of the study, Valeant had no role in study design, data analysis, data interpretation, or writing of the report. The present study was also supported by Silesian Analytical Laboratories (SLA), CHDE, BIO-RAD. The work of ALC has been supported by Ministry of Health - Ricerca Corrente - IRCCS Multi-Medica, PRIN 2017H5F943 and ERANET ER-2017-2364981. In addition, we would like to thank all volunteer investigators, all volunteer staff and all participants. The list of the LIPIDOGRAM 2015 investigators is presented in Supplementary material 3. This article is part of a Supplement entitled “Plasma lipids and cardio-vascular risk: Nutritional and therapeutic approaches” published with support from Societ a Italiana di Terapia Clinica e Sperimentale (SITeCS).
- Hits: 2225
- Visitors: 2189
- Downloads: 124
Thumbnail | File | Description | Size | Format | |||
---|---|---|---|---|---|---|---|
View Details Download | SOURCE1 | Published version | 1 MB | Adobe Acrobat PDF | View Details Download |